RenakBiotech Limited
Registered number: 13019171
Balance Sheet
as at 30 November 2023
2022 2022
£ £
Current assets
Cash at bank and in hand 0.1 0.1
0.1 0.1
Capital and reserves
Called up share capital 0.1 0.1
Shareholders' funds 0.1 0.1
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 480 of the Companies Act 2006 relating to dormant companies.
Members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. A profit and loss account has not been delivered to the Registrar of Companies.
James Adjaye
Director
Approved by the board on 1 March 2024
RenakBiotech Limited
Notes to the Accounts
for the year ended 30 November 2023
1 Accounting policies
The accounts have been prepared under the historical cost convention.
2 Other information
RenakBiotech Limited is a private company limited by shares and incorporated in England. Its registered office is:
85 Great Portland Street
First Floor
London
England
W1W 7LT
RenakBiotech Limited 13019171 true 2022-12-01 2023-11-30 2023-11-30 VT Final Accounts October 2023 release 2 James Adjaye No description of principal activity 13019171 core:ShareCapital 2022-11-30 13019171 2022-12-01 2023-11-30 13019171 bus:EntityHasNeverTraded 2022-12-01 2023-11-30 13019171 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 13019171 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 13019171 bus:Director40 2022-12-01 2023-11-30 13019171 countries:England 2022-12-01 2023-11-30 13019171 bus:FRS102 2022-12-01 2023-11-30 13019171 bus:FullAccounts 2022-12-01 2023-11-30 13019171 2023-11-30 13019171 core:ShareCapital 2023-11-30 13019171 2022-11-30 iso4217:GBP